Research and Application: Examples - Biomedical Informatics in Translational Research - page 226

[27] Ginns, E. I., et al., “A Genome-Wide Search for Chromosomal Loci Linked to Bipolar Affec-

tive Disorder in the Old Order Amish,” Nat. Genet. , Vol. 12, 1996, pp. 431-435.

[28] Imperatore, G., et al., “Sib-Pair Linkage Analysis for Susceptibility Genes for Microvascular

Complications Among Pima Indians with Type 2 Diabetes. Pima Diabetes Genes Group,”
Diabetes , Vol. 47, 1998, pp. 821-830.

[29] Gudbjartsson, D. F., et al., “Allegro, a New Computer Program for Multipoint Linkage

Analysis,” Nature Genetics, Vol. 25, 2000, pp. 12-13.

[30] Gudbjartsson, D. F., et al., “Allegro Version 2,” Nature Genetics, Vol. 37, 2005,

pp. 1015-1016.

[31] Hakonarson, H., et al., “Effects of a 5-Lipoxygenase-Activating Protein Inhibitor on

Biomarkers Associated with Risk of Myocardial Infarction: A Randomized Trial,” JAMA ,
Vol. 293, 2005, pp. 2245-2256.

[32] King, H., Aubert, R. E., and Herman, W. H., “Global Burden of Diabetes, 1995-2025:

Prevalence, Numerical Estimates, and Projections,” Diabetes Care , Vol. 21, 1998, pp.
1414-1431.

[33] Duggirala, R., et al., “Linkage of Type 2 Diabetes Mellitus and of Age at Onset to a Genetic

Location on Chromosome 10q in Mexican Americans,” Am. J. Hum. Genet. , Vol. 64, 1999,
pp. 1127-1140.

[34] Florez, J. C., et al., “TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes

Prevention Program,” N. Engl. J. Med. , Vol. 355, 2006, pp. 241-250.

[35] Zhang, C., et al., “Variant of Transcription Factor 7-Like 2 (TCF7L2) Gene and the Risk of

Type 2 Diabetes in Large Cohorts of U.S. Women and Men,” Diabetes , Vol. 55, 2006,
pp. 2645-2648.

[36] http://www.decodediagnostics.com/t2.php.

[37] Hu, H., et al., “Biomedical Informatics: Development of a Comprehensive Data Warehouse

for Clinical and Genomic Breast Cancer Research,” Pharmacogenomics , Vol. 5, 2004,
pp. 933-941.

[38] Ellsworth, R. E., et al., “Timing of Critical Genetic Changes in Human Breast Disease,”

Ann. Surg. Oncol. , Vol. 12, 2005, pp. 1054-1060.

[39] Ellsworth, R. E., et al., “Correlation of Levels and Patterns of Genomic Instability with

Histological Grading of Invasive Breast Tumors,” Breast Cancer Res. Treat. , Vol. 107,
2008, pp. 259-265.

[40] Ellsworth, R. E., et al., “Allelic Imbalance in Primary Breast Carcinomas and Metastatic

Tumors of the Axillary Lymph Nodes,” Mol. Cancer Res. , Vol. 3, 2005, pp. 71-77.

[41] Becker, T. E., et al., “Genomic Heritage of Axillary Lymph Node Metastases in Breast Can-

cer Patients,” Ann. Surg. Oncol. , 2008, 15(4): 1056-63.

[42] Maskery, S. M., et al., “Co-Occurrence Analysis for Discovery of Novel Breast Cancer

Pathology Patterns,” IEEE Trans. on Inf. Technol. Biomed. , Vol. 10, 2006, pp. 497-503.

[43] Maskery, S. M., et al., “A Bayesian Derived Network of Breast Pathology Co-Occurrence,”

J. Biomed. Inform. , 2008, 41(2): 242-50.

[44] Cancer Facts and Figures 2005, Atlanta, GA: American Cancer Society, 2005.

[45] Early Breast Cancer Trialists' Collaborative Group, “Polychemotherapy for Early Breast

Cancer: An Overview of the Randomised Trials,” The Lancet , Vol. 352, 1998,

pp. 930-942.

[46] Rosen, P., Rosen's Breast Pathology , 2nd ed., Philadelphia, PA: Lippincott Williams and

Wilkins, 2001.

[47] Fujii, H., et al., “Genetic Progression, Histological Grade, and Allelic Loss in Ductal Carci-

noma in situ of the Breast,” Cancer Res. , Vol. 56, 1996, pp. 5260-5265.

[48] Vos, C. B., et al., “Genetic Alterations on Chromosome 16 and 17 Are Important Features

of Ductal Carcinoma in situ of the Breast and Are Associated with Histologic Type,” Br. J.
Cancer , Vol. 81, 1999, pp. 1410-1418.